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ABSTRACT 
This second Small Animal Disease Surveillance report focuses on syndromic surveillance of i) 
respiratory disease in veterinary practice and ii) feline calicivirus (FCV) based on laboratory 
diagnosis, in a large veterinary-visiting pet population of the UK between January 2014 and 
December 2015. Presentation for respiratory disease comprised 1.7%, 2.3% and 2.5% of canine, 
feline and rabbit consultations, respectively. In dogs, the most frequent respiratory sign reported 
was coughing (71.1% of consultations), whilst in cats it was sneezing (42.6%). Cats had a higher 
number of geographical regions at high relative risk for respiratory disease compared with dogs in 
England and Wales. The mean percentage of samples testing positive for FCV was 30.1% (95% CI: 
28.2–32.2%) in the year 2014 and 27.9% (95% CI: 26.2–29.7%) in 2015. January was the month with 
the highest percentage of FCV positive samples in both years. The report also gives an update on 
influenza A virus in dogs and cats. Finally, in its section about topical developments in companion 
animal infection worldwide, the report briefly reminds us of the zoonotic potential of leptospirosis.  
UK SADS Report  Page 2 of 11          Sánchez-Vizcaíno et al. 
 
Format of the report 
This report comprises five sections. The first two summarise some practice- and laboratory-based 
surveillance, respectively: this report is focused on respiratory disease in practices and on 
laboratory-confirmed diagnosis of feline calicivirus (FCV) infection. The third section provides an 
update on the syndrome (gastrointestinal disease) analysed in the previous report for the study 
period between 1st October and 31st December 2015. The fourth section presents an update on 
influenza virus in dogs and cats. The final section describes other recent and relevant infectious 
disease events occurring in a global context that, have the potential to impact on small animal 
populations in the UK and the owners of those animals. 
1. Syndromic surveillance of respiratory disease  
The term ‘respiratory disease’ includes a wide range of conditions of the respiratory tract. Infections, 
especially viral infections, are an important cause of respiratory disease. Clinical signs may include 
coughing, sneezing, nasal and ocular discharges, lethargy and difficulty breathing. Here we describe 
animals presented primarily with respiratory disease to 199 veterinary practices (428 premises) 
between 1st January 2014 and 31st December 2015. The data were obtained from the Small Animal 
Veterinary Surveillance Network (SAVSNET). A detailed description of the methods used by SAVSNET 
to capture electronic health records (EHRs) may be found elsewhere (Sánchez-Vizcaíno et al., 2015). 
In total, EHRs for 1,000,245 consultations were collected (including repeat consultations for the 
same animal), of which 69.4% were from dogs, 26.5% cats, 1.5% rabbits, 1.3% other species and 
1.3% where the species was not noted. Presentation for respiratory disease, as indicated by the 
veterinary surgeon’s categorisation comprised 1.7%, 2.3% and 2.5% of canine, feline and rabbit 
consultations, respectively. Short questionnaires relating to presenting signs, diagnostic tests and 
treatments (Sánchez-Vizcaíno et al., 2015) were completed for 3,596 animals based on a single 
questionnaire per patient. The results related to the clinical signs at presentation are shown in Table 
1. A high proportion of dogs (55.6%) and cats (45.8%) were presented after only a short history of 
illness (average of six days). Diagnostic tests were planned in 18.7% of dogs and 19.6% of cats with 
respiratory disease, with radiography and haematological/biochemical analyses being most 
common. 
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Table 1. Percentage of clinical signs in 2,419 dogs and 1,177 cats presenting with respiratory disease 
to veterinary practices in the UK. The same animal could present with more than one sign per 
consultation. 
Clinical signs Number (%) of dogs Number (%) of cats 
Conjunctivitis and/or ocular discharge 
Coughing  
Drooling  
Dyspnoea 
Generalised depression/lethargy 
Mouth ulcers 
Nasal discharge  
Pyrexia 
60 (2.5) 
1,719 (71.1) 
16 (0.7) 
329 (13.6) 
108 (4.5) 
4 (0.2) 
176 (7.3) 
90 (3.7) 
190 (16.1) 
308 (26.2) 
22 (1.9) 
251 (21.3) 
107 (9.1) 
17 (1.4) 
329 (27.9) 
69 (5.9) 
Sneezing 366 (15.1) 502 (42.6) 
Other signs 254 (10.5) 157 (13.3) 
 
The spatial distribution of the relative risk for respiratory disease was evaluated in dogs and cats in 
England and Wales for each season of the year (Figure 1). Estimates for Scotland and Northern 
Ireland are not included in this report because SAVSNET geographical coverage in these areas is 
currently limited. Animals were considered as “cases” if, during the season assessed, they were 
presented for respiratory disease at one or more consultations. A kernel smoothing method was 
used to smooth the spatial variation of the relative risk for respiratory disease throughout England 
and Wales. The relative risk of dogs being presented with respiratory disease was estimated as the 
ratio of kernel-smoothed intensities (i.e. mean number of events estimated per unit area) of dogs 
presented with respiratory disease (cases) compared with all dogs presented to SAVSNET veterinary 
practices for a cause other than respiratory disease (controls); the same approach was conducted 
for cats. Estimations were made using a grid cell of 5 km and a bandwidth of 50 km. 
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Figure 1. Kernel intensity ratio surface of England and Wales showing the relative risk of dogs and 
cats being presented with respiratory disease by season. The colours for relative risk have been 
categorised using the four cut-offs that divide the results obtained from cats during spring into five 
equal-size groups (quintiles) each containing 20% of all results. 
In dogs, a low number of zones at high relative risk for respiratory disease were identified in autumn 
and spring, with winter and summer having no zones of high relative risk. In contrast, cats had a 
higher number of zones at high relative risk for respiratory disease compared with dogs. Most of 
these areas appeared transient, although some areas in Wales and South West of England seemed 
to have a higher relative risk throughout the year. Together, these data reaffirm the different 
pattern of presentation for respiratory disease between cats and dogs, and suggest that the relative 
risk for respiratory disease varies spatially and temporally. It should be noted these zones may not 
equate to outbreaks; SAVSNET is currently developing models to allow outbreaks to be identified. 
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 2. Laboratory-based surveillance of feline calicivirus in the UK 
Feline calicivirus (FCV) is one of the two most important viral causes of respiratory infection in cats, 
the other being feline herpesvirus 1 (FeHV-1) (Radford and others 2009).  Acute signs of FCV include 
fever, conjunctivitis, nasal discharge, sneezing, and lameness, although perhaps the most consistent 
sign is oral ulceration. More rarely, pneumonia may develop with secondary bacterial infections. On 
recovery from clinical disease, many cats develop a carrier state and continue to shed the virus. As a 
result, approximately 10% of clinically normal cats test positive for FCV, although much higher 
figures can be found where cats are housed in groups.  
SAVSNET data gathered from participating laboratories (Sánchez-Vizcaíno et al., 2015) were used to 
identify temporal and geographical trends in the proportion of samples testing positive for FCV using 
either virus isolation or PCR (Figure 2). Proportions are currently used to protect the case loads of 
participating laboratories. Samples were submitted from 116 of the 121 postcode areas in use in the 
UK. The mean percentage of samples testing positive for FCV was 30.1% (95% CI: 28.2–32.2%) in the 
year 2014 and 27.9% (95% CI: 26.2–29.7%) in 2015. January was the month with the highest 
percentage of positive samples in both 2014 (31.7%, 95% CI: 24.0–40.4%) and 2015 (36.0%, 95% CI: 
29.5–43.1%). However, the confidence intervals (95% CI) indicate that the real percentage of 
samples testing positive for FCV could be the same for all months; in a future analysis we will 
determine whether this apparent temporal trend continues. From postcode areas that submitted 25 
or more samples in each year, the highest percentage of samples testing positive were from 
Gloucester (48% in 2014) and Bristol (39% in 2015). In total, 10 postcode areas in 2014 and 14 in 
2015 submitted only negative samples; these areas only had low sample numbers. Colchester in 
2014 and Liverpool in 2015 submitted the highest numbers of these negative samples (13 and 8, 
respectively). These apparent temporal and spatial variations suggest a potential different 
epidemiology for FCV infection across the country, and will need further study. Results presented 
here should currently be interpreted with caution as some postcode areas of the UK had small 
numbers of submissions during this sample period. Similar results for other pathogens including 
FeHV-1 are available in near-real time through the SAVSNET website. 
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Figure 2. Temporal and geographical trends in feline calicivirus (FCV) diagnosis. a) and b) 
Geographical distribution of the percentage of samples testing positive for FCV by postcode area. An 
asterisk (*) identifies the area with the highest percentage of positive FCV samples in each year from 
those postcode areas that submitted at least 25 samples. A triangle (▲) identifies the FCV negative 
postcode area which submitted the highest number of samples in each time period. c) and d) 
Percentage of samples which test positive for FCV by month (the dotted line indicates the mean 
percentage of samples testing positive in each year). 
3. Update on previous reports. 
Update on gastrointestinal disease  
In total, EHRs for 342,031 individual consultations were recorded from 174 practices (366 sites) 
between October and December 2015. Of these, 68.5% were from dogs, 28.1% cats, 1.1% rabbits, 
0.9% other species and 1.3% where the species was not noted. Presentation for gastrointestinal (GI) 
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disease comprised 4.1% of canine consultations and 3.1% of feline consultations. These figures were 
slightly lower than those obtained for the same monthly period in the year 2014 (4.4% and 3.3% of 
canine and feline consultations, respectively).  
In total, 2,623 GI disease questionnaires (1,934 dogs, 612 cats) based on a single questionnaire per 
patient were collected between October and December 2015. The two most frequent GI clinical 
signs reported in dogs and cats were vomiting without blood (39.8% of dog GI disease consultations 
and 35.1% of cat GI disease consultations) and diarrhoea without blood (37.6% and 36.3%, 
respectively). A high proportion of dogs (52.8%) and cats (40.2%) were presented after only a short 
history of illness over the previous two days. Diagnostic tests were planned in 23.8% of dogs and 
30.9% of cats with GI disease, with haematological/biochemical analyses being most common.  
The spatial distribution of the relative risk for GI disease in dogs and cats was assessed in England 
and Wales for each season of the year using data for two completed years between 2014 and 2015. 
The results obtained from the GI disease questionnaires and the pattern of presentation for GI 
disease found in dogs and cats (results not presented here) were similar as the one shown in a 
previous study using data from January 2014 to September 2015 (Sánchez-Vizcaíno et al., 2015).   
4. Update on influenza virus in dogs and cats. 
We all know Influenza viruses are an important cause of respiratory disease in humans. Here we 
present an update on their evolving interaction with our cats and dogs.  
Influenza A viruses are archetypal emergent viruses; their segmented RNA genome makes them 
highly adaptable. They are classified into many different subtypes based on their surface 
glycoproteins: haemagglutinin (HA) and neuraminidase (NA).  Waterfowl are important reservoir 
hosts of the majority of influenza A subtypes.  Historically, certain subtypes have ‘spilled over’ into 
mammalian species, occasionally establishing themselves in their new host (reviewed in Short et al., 
2015). 
Transmission of avian influenza viruses to domestic fowl has occurred with apparently increasing 
frequency in recent decades. In chickens and turkeys, H5 or H7 subtypes can evolve from low 
pathogenicity to highly pathogenic avian influenza (HPAI) (Short et al., 2015). Instead of being 
restricted to the respiratory tract, these HPAI viruses are disseminated throughout the body: such 
viruses are notifiable. Mammals coming into close contact with HPAI infected birds (e.g. tigers fed 
carcasses of infected chickens in a zoo) are exposed to high doses of virus and can also become 
infected. These individuals are generally considered dead-end hosts. Apart from isolated incidences 
of HPAI infections, other influenza A viruses had not been associated with disease in dogs or cats 
until earlier this century. 
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In 2005, researchers in the US reported that an equine-origin H3N8 influenza virus was responsible 
for a respiratory disease outbreak in greyhounds in Florida (Crawford et al., 2005). Serological 
analysis confirmed that the virus had probably been circulating in racing greyhounds since the late 
1990s. This virus has now moved into other dog populations (e.g. dogs in animal shelters), spreading 
across the USA and now has endemic status; vaccines against it are available.  
Has this virus occurred outside the USA? A retrospective study in the UK implicated a closely related 
equine influenza A H3N8 virus in at least one outbreak of respiratory disease in English foxhounds 
(Daly et al., 2008). Dogs also became infected during an H3N8 influenza A outbreak in Australian 
horses (Kirkland et al., 2010). That these viruses have not yet established in dog populations outside 
the USA is possibly due to the more isolated nature of the dogs in which the initial spill-over events 
occurred. The risk to the UK comes from importation of infected animals from the USA or from 
sporadic new spill-over events where horses and dogs are kept in close proximity. 
There have also been isolated cases of confirmed human influenza A H1N1 virus infection in dogs 
and cats (e.g. ProMED: 20091128.4079) (Sponseller et al., 2010). Of current interest, avian H3N2 
influenza emerged in dogs in Korea in 2007 (Song et al., 2008), arriving in the US in 2015, possibly 
with imported rescue dogs (ProMED: 20150413.3293591). This virus has subsequently spread, 
resulting in its co-circulation with H3N8 virus in dogs in the USA.  Vaccines containing the H3N2 
strain have been granted a conditional license for use in susceptible dog populations.   
In the UK, clinicians should be aware of the potential for influenza virus infection in dogs (or cats) 
with respiratory disease in some rare circumstances. These include close contact with horses or 
people with influenza-like illness, and potential exposure through travel to, or contact with, animals 
from the USA or the Far East. People should also be aware of the possibility of transmission to cats 
when/if there is an outbreak of HPAI in birds in their area; veterinarians should remember that this 
disease is notifiable.  
Typical clinical signs of mammalian influenza are similar across different species and include fever, 
cough and malaise. Nasal discharge, that is initially serous, may become mucopurulent due to 
secondary bacterial infection. HPAI infection of cats is often fatal. Treatment of influenza is 
symptomatic (rest and hydration), but administration of antibiotics may be warranted if secondary 
bacterial infection occurs. Diagnostic testing for influenza virus is generally not routinely performed 
for cats and dogs presenting with acute respiratory disease in the UK. However, several laboratories 
now offer a Respiratory Pathogen PCR screening test that includes detection of influenza A virus. A 
preliminary screen of laboratory data submitted to SAVSNET shows that positive tests are 
occasionally recorded and suggests further work on the role of these viruses in UK dog and cat 
populations is warranted.  
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5. A global perspective on companion animal infection  
The last three months of 2015 were relatively quiet for global infection stories in small pet animal 
species. Of course quite rightly, everyone is talking about Zika virus and its worrying implications 
particular for pregnant woman. In this report it is perhaps worth emphasising that apart from 
monkeys, there is no evidence to suggest Zika virus causes disease in other animals such as cats, 
dogs, rabbits and other small pet animals or that these pet animals are involved in transmission 
(http://www.cdc.gov/zika/transmission/qa-animals.html).  
Leptospirosis. A fatal case of human leptospirosis was investigated by Public Health England (PHE) at 
an Animal Shelter in the UK in December 2015, a reminder of the zoonotic potential of this 
organism. PHE investigates 50-100 cases of leptospirosis per year, with most associated with animal 
or water exposure (Schuller et al., 2015, https://www.gov.uk/guidance/leptospirosis). The most 
frequently implicated animals include rats, cattle and pigs. Clearly dogs can also carry leptospirosis, 
and dog to human transmission is described, but seems rare (Sykes et al., 2011, LEVETT 2001).  Cats 
can also be infected with leptospires, but clinical signs are rarely described. 
The bacteria enter the body through abrasions or cuts in the skin and through the lining of the nose, 
mouth and eyes. Clinical signs are not always present in dogs but where they are they can be severe 
reflecting renal, hepatic and respiratory impairment, and less frequently disseminated intravascular 
coagulation. Diagnosis is not always straightforward and includes serology (microscopic 
agglutination test) as well as PCR on blood or urine. Data reported to SAVSNET shows that ~6% and 
9% of blood and urine samples test PCR positive respectively, testament to the ongoing significance 
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of this pathogen in dogs. Treatment includes intravenous penicillin derivatives or oral doxycycline, 
coupled with specific treatment relating to individual organs affected.  Vaccination of dogs is 
recommended in countries where there is a significant risk of infection (Schuller et al., 2015, Day et 
al., 2016). 
According to the Health and Safety Executive, farmers are now the main risk group for Leptospira 
infection (http://www.hse.gov.uk/pubns/indg84.pdf). Other people who have contracted 
leptospirosis in recent years include veterinarians, meat inspectors, butchers, and abattoir and 
sewer workers. Workers in contact with canal and river water are also at risk. 
Simple precautions can reduce the risk of contracting leptospirosis: cover cuts, scratches or sores 
with a waterproof plaster and thoroughly clean cuts or abrasions; wear appropriate protective 
clothing, gloves or protective footwear; wash or shower promptly after water sports, especially if 
you fall in; wear thick gloves when handling rats; wash hands after handling any animal, and before 
eating.  
Conclusion 
This is the second UK SADS report highlighting the importance of respiratory disease in UK pet 
animals. In the future, we will expand to other syndromes including skin disease and tumours. As we 
collect data for longer, our estimates of changes in disease burden will become more refined, 
allowing more targeted local and perhaps national interventions. Anonymised data can be accessed 
for research by contacting the authors. SAVSNET welcomes your feedback. 
Acknowledgements 
The SAVSNET team is extremely grateful to the veterinary practices and diagnostic laboratories that 
participated in this study by providing data and without whose support these reports would not 
have been possible. We especially wish to thank, in alphabetical order, BioBest, CAPL, CTDS, CVS, 
Idexx, Lab Services Ltd, Langford Veterinary Services, NationWide Laboratory Services, PTDS, SRUC, 
Teleos, TDDS and VetSolutions (the suppliers of RoboVet and PremVet). We would also like to thank 
Susan Bolan, SAVSNET project administrator, for her help and support. 
References 
DAY, M.J., HORZINEK, M.C., SCHULTZ, R.D., SQUIRES, R.A. (2016). WSAVA Guidelines for the 
vaccination of dogs and cats. Journal of Small Animal Practice 57, E1-E45. 
UK SADS Report  Page 11 of 11          Sánchez-Vizcaíno et al. 
 
LEVETT, P.N. (2001). Leptospirosis. CLINICAL MICROBIOLOGY REVIEWS, Vol. 14, No. 2 p. 296–326. 
RADFORD, A.D., ADDIE, D., BELÁK, S., BOUCRAUT-BARALON, C., EGBERINK, H., FRYMUS, 
T., GRUFFYDD-JONES, T., HARTMANN, K., HOSIE, M.J., LLORET, A., LUTZ, H., MARSILIO, F., PENNISI, 
M.G.,THIRY, E., TRUYEN, U., HORZINEK, M.C. (2009). Feline calicivirus infection. ABCD guidelines on 
prevention and management. Journal of Feline Medicine and Surgery 11, 556-564. 
SÁNCHEZ-VIZCAÍNO, F., JONES, P.H., MENACERE, T., HEAYNS, B., WARDEH, M., NEWMAN, J., 
RADFORD, A.D., DAWSON, S., GASKELL, R., NOBLE, P.J., EVERITT, S., DAY, M.J., MCCONNELL, K. 
(2015). Small animal disease surveillance. Veterinary Record 177, 591-594. 
SCHULLER, S., FRANCEY, T., HARTMANN, K., HUGONNARD, M., KOHN, B., NALLY J.E., SYKES J. (2015). 
European consensus statement on leptospirosis in dogs and cats. Journal of Small Animal Practice 
56, 159–179. 
SYKES, J.E., HARTMANN, K., LUNN, K.F., MOORE, G.E. STODDARD R.A., GOLDSTEIN R.E. (2011).  2010 
ACVIM Small Animal Consensus Statement on Leptospirosis: Diagnosis, Epidemiology, Treatment, 
and Prevention. Veterinary Internal Medicine 25, pages 1–13. 
 
 
